Literature DB >> 225456

A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.

V A Levin, C B Wilson, R Davis, W M Wara, T L Pischer, L Irwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 225456     DOI： 10.3171/jns.1979.51.4.0526

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  20 in total

Review 1.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

2.  Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas.

Authors:  T Trojanowski; J Peszyński; K Turowski; S Kamiński; I Gościński; M Reinfus; T Krzyszkowski; M Pyrich; A Bielawski; C Leszczyk
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

Review 3.  Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.

Authors:  Charles A Kunos; Evanthia Galanis; Jeffrey Buchsbaum; Qian Shi; Lewis C Strauss; C Norman Coleman; Mansoor M Ahmed
Journal:  J Neurooncol       Date:  2017-05-30       Impact factor: 4.130

4.  Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults.

Authors:  M Matsutani; O Nakamura; M Nakamura; T Nagashima; A Asai; T Fujimaki; H Tanaka; K Ueki; Y Tanaka
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Intra-operative radiation therapy for malignant brain tumors: rationale, method, and treatment results of cerebral glioblastomas.

Authors:  M Matsutani; O Nakamura; T Nagashima; A Asai; T Fujimaki; H Tanaka; M Nakamura; K Ueki; Y Tanaka; T Matsuda
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 6.  Chemotherapy of malignant gliomas.

Authors:  Y Ushio; T Hayakawa; H Hasegawa; K Yamada; N Arita
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

7.  Cisplatin and etoposide combination therapy for primary glial tumors: preliminary results.

Authors:  A Boiardi; A Silvani; I Milanesi; L Munari; C L Solero; M Botturi
Journal:  Ital J Neurol Sci       Date:  1991-02

8.  Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.

Authors:  Annick Desjardins; David A Reardon; James E Herndon; Jennifer Marcello; Jennifer A Quinn; Jeremy N Rich; Sith Sathornsumetee; Sridharan Gururangan; John Sampson; Leighann Bailey; Darell D Bigner; Allan H Friedman; Henry S Friedman; James J Vredenburgh
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

9.  A pilot study of cis-diamminedichloroplatinum and radiation therapy in patients with high grade astrocytomas.

Authors:  L G Feun; D J Stewart; M Maor; M Leavens; N Savaraj; M A Burgess; W K Yung; R S Benjamin
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

10.  Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.

Authors:  P Paoletti; G Butti; R Knerich; P Gaetani; R Assietti
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.